Business Briefing: Gilead Ordered to Pay Merck $200 Million in Patent Dispute

A federal jury on Thursday ordered Gilead Sciences to pay for infringing two Merck patents related to a lucrative cure for hepatitis C.











from NYT > Health http://ift.tt/1UMjXbx
via health&fitness